Table 6 Drug susceptibility analysis according to SDC1
From: Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
Drug | cor | pvalue | Drug | cor | pvalue |
|---|---|---|---|---|---|
Imexon | -0.4446 | 0.0004 | Dacarbazine | -0.2953 | 0.0220 |
Nilotinib | -0.4434 | 0.0004 | Pipamperone | -0.2896 | 0.0248 |
Chelerythrine | -0.4260 | 0.0007 | Ixazomib citrate | -0.2896 | 0.0248 |
Arsenic trioxide | -0.4180 | 0.0009 | Selumetinib | -0.2820 | 0.0290 |
Bafetinib | -0.4174 | 0.0009 | XK-469 | -0.2782 | 0.0314 |
Cyclophosphamide | -0.4149 | 0.0010 | ABT-199 | -0.2765 | 0.0325 |
Hypothemycin | -0.4078 | 0.0012 | Bendamustine | -0.2728 | 0.0349 |
Lapachone | -0.3699 | 0.0036 | Imatinib | -0.2618 | 0.0433 |
Dimethylaminoparthenolide | -0.3690 | 0.0037 | BN-2629 | -0.2584 | 0.0462 |
Carmustine | -0.3545 | 0.0055 | Oxaliplatin | -0.2571 | 0.0474 |
Nelarabine | -0.3522 | 0.0058 | Irofulven | 0.2683 | 0.0382 |
Vorinostat | -0.3501 | 0.0061 | Dasatinib | 0.2746 | 0.0337 |
Ifosfamide | -0.3475 | 0.0065 | Itraconazole | 0.2772 | 0.0320 |
Bortezomib | -0.3459 | 0.0068 | Everolimus | 0.2965 | 0.0214 |
Lomustine | -0.3113 | 0.0155 | kahalide f | 0.3064 | 0.0173 |